2025-11-11T10:55:06-06:00 2025-06-30 420714325 RSM US LLP 9801 WASHINGTONIAN BLVD STE 500 GAITHERSBURG MD 20878 990 2024-07-01 200065799 QLARANT FOUNDATION INC QLAR 4108220697 28464 MARLBORO AVENUE EASTON MD 21601 CHRISTINE LEISTER CHIEF FINANCIAL OFFICER 4108220697 2025-11-09 1 1 JULIA FLANNERY P00928918 3012963600 2025-11-09 2024 2025-03-06 01:10:19Z RONALD FORSYTHE 28464 MARLBORO AVENUE EASTON MD 21601 2532248 0 X WWW.QLARANT.COM X 2003 MD THE QLARANT FOUNDATION SUPPORTS ACTIVITIES THAT PROMOTE COMMUNITY HEALTH. SEE SCHEDULE O. THE QLARANT FOUNDATION ALSO SUPPORTS ACTIVITES THAT ENHANCE THE QUALITY OF LIFE OF INDIVIDUALS WHO ARE IN DEFINED COMMUNITIES OR MEMBERS OF VULNERABLE POPULATIONS. 7 7 1 0 0 0 1622000 1687000 0 0 603019 835248 0 10000 2225019 2532248 413000 2200 0 0 74904 218526 0 0 0 80864 94905 568768 315631 1656251 2216617 20679744 23884563 444093 4998 20235651 23879565 ASSESS THE EFFECTIVENESS AND EFFICIENCY OF HEALTH & HUMAN SERVICES. ASSIST HEALTH AND HUMAN SERVICE PROVIDERS IN IMPLEMENTING PROCESS IMPROVEMENT ACTIVITIES IN THEIR RESPECTIVE LOCATIONS OF CARE. 0 0 2200 2200 THE QLARANT FOUNDATION, INC MADE GRANTS TO VARIOUS HEALTHCARE ORGANIZATIONS WHICH SUPPORTED INNOVATIONS IN IMPROVING HEALTHCARE AND QUALITY OF LIFE FOR THE DEFINED COMMUITIES AND THE GENERAL PUBLIC. 2200 1 1 0 1 0 0 0 0 0 0 0 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 7 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 7 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 X CHRISTINE LEISTER CFO 4108220697 28464 MARLBORO AVENUE EASTON MD 21601 AMANDA NEAL CHAIR (THRU 09/24), EXECUTIVE DIRECTOR 40.00 1.00 X X 39037 10693 2672 LAMONT THOMPSON DIRECTOR, CHAIR (BEG 09/24) 3.00 X X 4248 0 0 CHANTE'L BRADY DIRECTOR 1.00 2.50 X 3564 11881 0 MARY B BURGOYNE MD DIRECTOR 1.50 X 3564 0 0 BRENDA L CRABBS SECRETARY 1.00 X X 3564 0 0 MICHAEL FISHER DIRECTOR 2.00 X 3564 0 0 NANCY HOLMES DIRECTOR 7.00 X 3564 0 0 DIANE MCCOMB DIRECTOR, VICE CHAIR (BEG 1/25) 3.00 X X 3564 0 0 RONALD FORSYTHE CEO - QLARANT 1.00 54.00 X 0 866616 96831 JEFFREY WEISS CFO - QLARANT (THRU 10/24) 1.00 49.00 X 0 355816 39191 CHRISTINE LEISTER CFO - QLARANT (BEG 10/24) 1.00 49.00 X 0 212100 63932 64669 1457106 202626 0 0 1 0 0 1687000 1687000 835248 835248 OTHER INCOME 900099 10000 10000 10000 2532248 0 0 845248 2200 2200 199899 199899 18627 18627 45109 45109 13000 13000 1312 1312 21714 21714 8913 8913 437 437 3933 3933 487 487 315631 2200 313431 0 73887 24631 0 50000 14567080 19552566 4416777 2637003 1622000 1620363 20679744 23884563 415000 4998 29093 0 444093 4998 X 20235651 23879565 20235651 23879565 20679744 23884563 2216617 1427297 0 X 0 1 X 1 0 X 500000 1043000 1622000 1687000 4852000 500000 1043000 1622000 1687000 4852000 4852000 386009 651374 512712 603019 835248 2988362 2289 749 10000 13038 7853400 0.61780 0.58510 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 315631 110616275 315631 110616275 63126 1000000 15782 250000 0 0 0 0 1000000 1000000 1000000 1000000 4000000 6000000 250000 250000 250000 250000 1000000 1500000 0 AMERICAN FUNDS WASHINGTON MUTUAL INVESTORS CLASS F3 1384715 F VANGUARD VALUE INDEX FUND ADMIRAL SHARES 1252288 F 2637003 DUE FROM RELATED PARTY 1620363 1620363 X 114626830 1427297 110667285 112094582 2532248 0 2532248 108257630 107941999 107941999 315631 0 315631 PART X, LINE 2: THE COMPANY FOLLOWS THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, THE COMPANY MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION CLASSIFICATION, INTEREST, PENALTIES ON INCOME TAXES AND ACCOUNTING IN INTERIM PERIODS. MANAGEMENT HAS EVALUATED THE COMPANY'S TAX POSITIONS AND HAS CONCLUDED THAT THE COMPANY HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISION OF THIS GUIDANCE. PART XI, LINE 2D - OTHER ADJUSTMENTS: REVENUE FROM AFFILIATES INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 110,667,285. PART XII, LINE 2D - OTHER ADJUSTMENTS: EXPENSES FROM AFFILIATES INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 107,941,999. 0 1 0 0 0 0 0 0 0 RONALD FORSYTHE CEO - QLARANT 0 664619 0 193691 0 8306 0 59521 0 37310 0 963447 0 0 JEFFREY WEISS CFO - QLARANT (THRU 10/24) 0 275599 0 79875 0 342 0 10608 0 28583 0 395007 0 0 CHRISTINE LEISTER CFO - QLARANT (BEG 10/24) 0 190856 0 20158 0 1086 0 19949 0 43983 0 276032 0 0 PART I, LINE 4B CEO, RON FORSYTHE, PARTICIPATES IN A 457(F) PLAN. THERE WERE NO CONTRIBUTIONS INTO THE PLAN DURING 2024. SCHEDULE J, PART I, LINE 3 A COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, FORM 990 OF OTHER ORGANIZATIONS, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE WAS USED BY QLARANT, INC., A RELATED 501(C)(3) ORGANIZATION, TO ESTABLISH THE COMPENSATION OF THE ORGANIZATION'S CEO. FORM 990, PART VI, SECTION A, LINE 3 MANAGEMENT FUNCTIONS, SUCH AS FINANCE, HUMAN RESOURCES, INFORMATION TECHNOLOGY, CONTRACTS, AND BUSINESS DEVELOPMENT, ARE PERFORMED BY QLARANT, INC., THE FOUNDER OF QLARANT FOUNDATION, INC. FORM 990, PART VI, SECTION A, LINE 6 QLARANT, INC. IS THE SOLE MEMBER OF QLARANT FOUNDATION, INC. FORM 990, PART VI, SECTION A, LINE 7A QLARANT, INC. HAS THE RIGHT TO APPOINT AND ELECT ALL DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B THE BOARD OF DIRECTORS OF QLARANT, INC. APPROVES ALL BOARD MEMBER RECOMMENDATIONS MADE BY THE BOARD OF QLARANT FOUNDATION,INC. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE CEO, CFO, AND THE FINANCE COMMITTEE. THE BOARD OF DIRECTORS RECEIVES A COPY OF THE RETURN PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS PARTICIPATES IN ANNUAL COMPLIANCE TRAINING AND CONFLICT OF INTEREST TRAINING GIVEN BY THE COMPLIANCE OFFICER. EACH BOARD MEMBER, THE CEO, AND CFO ARE REQUIRED TO COMPLETE AND SIGN A CONFLICT OF INTEREST QUESTIONNAIRE ON AN ANNUAL BASIS. THERE MAY BE A MATTER WHERE A MEMBER, OR A MEMBER OF THE MEMBER'S FAMILY, MAY HAVE A MATERIAL PERSONAL INTEREST IN A TRANSACTION OR COURSE OF ACTION IN WHICH QLARANT FOUNDATION, INC. IS, OR MAY BE, INVOLVED. IN SUCH CIRCUMSTANCES, THE MEMBER SHALL NOT PARTICIPATE IN THE VOTING UPON, OR DISCUSSION OF, THE MATTER EXCEPT UNDER THE FOLLOWING CIRCUMSTANCES: 1. A REQUEST TO PARTICIPATE IS MADE TO THE COMPLIANCE COMMITTEE ALONG WITH FULL DISCLOSURE OF THE POTENTIAL CONFLICT AND ALL RELEVANT FACTS; AND 2. THE COMPLIANCE COMMITTEE DETERMINES THAT A MATERIAL PERSONAL INTEREST IS NOT INVOLVED; AND 3. THE BOARD IS FULLY ADVISED OF THE COMPLIANCE COMMITTEE'S DETERMINATION. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR ALL ASSOCIATES IS MANAGED THE SAME WAY WITH EXCEPTION OF THE CEO. HR IS RESPONSIBLE FOR ENSURING THAT EACH POSITION IS GRADED PROPERLY BASED ON EXTERNAL BENCHMARK DATA. COMPENSATION FOR THE VARIOUS POSITION RANGES ARE IN COMPLIANCE WITH LOCAL REQUIREMENTS, WHERE REQUIRED, AND EXTERNALLY BENCHMARKED TO ENSURE APPROPRIATE EQUITY. ANNUALLY, THE MERIT CONTRIBUTION ASSUMPTIONS ARE APPROVED BY THE BOARD. HR THEN OVERSEES EXECUTION OF THE MERIT PLANNING PROCESS BY THE ORGANIZATION BASED ON APPROVED BOARD ASSUMPTIONS. THE CEO REVIEWS THE OVERALL PLAN WITH THE VICE PRESIDENT OF HR FOR COMPLIANCE AND APPROPRIATE DISTRIBUTION BASED ON EMPLOYEE PERFORMANCE AND ALIGNMENT WITH OVERALL COMPENSATION PAY RANGES. THIS COMMON PROCESS IS FOLLOWED FOR ALL COMPANY EMPLOYEES WITH EXCEPTION OF THE CEO. THE EXECUTIVE BOARD REVIEWS AND APPROVES COMPENSATION OF THE CEO ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). QLARANT INC 28464 MARLBORO AVENUE EASTON MD 21601 263670453 HOLDING COMPANY MD 501(C)(3) LINE 12B, II N/A 0 QLARANT ADVISORY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 522334320 HEALTH ASSESSMENT DC 501(C)(3) LINE 7 QLARANT INC 0 QLARANT QUALITY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521000082 HEALTH ASSESSMENT MD 501(C)(3) LINE 7 QLARANT INC 0 QLARANT INTEGRITY SOLUTIONS LLC 28464 MARLBORO AVENUE EASTON MD 21601 203796994 HEALTH ASSESSMENT MD 501(C)(3) LINE 10 QLARANT INC 0 QLARANT COMMERCIAL SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521798961 PATIENT SAFETY PRODUCTS & SERVICES MD N/A C 0 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 QLARANT QUALITY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521000082 X 0 0 0 18665136 18665136 1000000 250000 0 0 0 QLARANT INC 28464 MARLBORO AVENUE EASTON MD 21601 263670453 0 0 0 760054 760054 139008 34752 0 0 0 QLARANT ADVISORY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 522334320 X 0 0 0 0 0 0 0 0 0 0 QLARANT FOUNDATION INC 28464 MARLBORO AVENUE EASTON MD 21601 200065799 X 0 0 0 315631 315631 63126 15782 0 0 0 QLARANT INTEGRITY SOLUTIONS LLC 28464 MARLBORO AVENUE EASTON MD 21601 203796994 0 0 0 90875454 90875454 1000000 250000 0 0 0